Lixte Biotechnology Holdings, Inc. (LIXT)

LIXT Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	5	5	8	16	40	8
Market Cap Growth	-44.84%	-37.62%	-48.20%	-59.29%	428.77%	-15.54%
Enterprise Value	2	1	3	12	35	5
PE Ratio	-	-1.04	-1.34	-2.43	-12.31	-3.11
PB Ratio	1.72	1.32	1.64	3.42	8.02	3.12
P/FCF Ratio	-1.99	-1.23	-1.84	-3.95	-18.85	-4.54
P/OCF Ratio	-1.99	-1.23	-1.84	-3.95	-18.85	-4.54
EV/EBITDA Ratio	-0.90	-0.21	-0.49	-1.72	-10.77	-2.05
EV/EBIT Ratio	-0.90	-0.21	-0.49	-1.72	-10.77	-2.05
EV/FCF Ratio	-1.10	-0.25	-0.68	-2.78	-16.47	-2.99
Quick Ratio	7.38	13.39	13.53	15.92	23.41	10.92
Current Ratio	7.76	13.73	14.05	16.81	24.15	11.23
Interest Coverage	-238.83	-312.38	-710.27	-906.53	-887.65	-
Return on Equity (ROE)	-127.30%	-129.70%	-112.00%	-106.00%	-132.20%	-79.40%
Return on Assets (ROA)	-115.60%	-119.90%	-103.00%	-101.30%	-121.40%	-73.30%
Return on Capital (ROIC)	-149.92%	-127.42%	-122.19%	-140.29%	-65.17%	-102.30%
Earnings Yield	-87.25%	-96.24%	-74.50%	-41.13%	-8.13%	-32.12%
FCF Yield	-70.89%	-81.22%	-54.43%	-25.33%	-5.30%	-22.03%
Buyback Yield / Dilution	-35.10%	-21.10%	-17.41%	-19.48%	-0.92%	-14.04%
Total Shareholder Return	-35.10%	-21.10%	-17.41%	-19.48%	-0.92%	-14.04%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).